Experts add that while the introduction of branded generics will trigger an acceleration in volumes for GLP-1 agonists, the value growth may moderate due to price erosion
Aurobindo Pharma subsidiary Eugia Pharma has launched generic Pomalidomide Capsules in the US, one of the first-to-file applicants for the drug, expanding its oncology portfolio
Biosimilars have the potential to offer affordable treatment to many currently untreatable diseases but striking a balance between affordability and regulation will be crucial